Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Too much androgen can cause hair loss; finasteride may help.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Finasteride improves hair loss in women with hyperandrogenism.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.